Todd A Kerensky

Nail Psoriasis: A Review of Treatment:

A. Gottlieb, Todd A Kerensky, Todd A. Kerensky, 2010 .

Opioid overdose prevention and naloxone rescue kits: what we know and what we don’t know

Todd Kerensky, Alexander Y. Walley, A. Walley, 2017, Addiction Science & Clinical Practice.

Association between pediatric psoriasis and the metabolic syndrome.

A. Gottlieb, M. Natter, P. Lizzul, 2012, Journal of American Academy of Dermatology.

Prevalence of the Metabolic Syndrome in Children with Psoriatic Disease

A. Gottlieb, J. Kulig, P. Lizzul, 2013, Pediatric dermatology.

Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis

A. Gottlieb, P. Lizzul, Noori Kim, 2013, The Journal of dermatological treatment.

Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment.

J. Samet, P. Roy, A. Walley, 2017, Journal of substance abuse treatment.

Etanercept: efficacy and safety for approved indications

A. Gottlieb, S. Au, Todd A Kerensky, 2012, Expert opinion on drug safety.

Non-prescription Fentanyl Positive Toxicology: Prevalence, Positive Predictive Value of Fentanyl Immunoassay Screening, and Description of Co-substance Use.

Marc R. Larochelle, A. Walley, Todd A Kerensky, 2020, Journal of addiction medicine.